The future of electric vehicles depends on battery packs that are safe, efficient, and easy to maintain. Wireless battery-management systems introduce a new way to cover all of these needs. What’s the ...

Bristol Myers Squibb and insitro first partnered in 2020 to develop induced pluripotent stem cell models of amyotrophic lateral sclerosis and frontotemporal dementia. Last December, BMS exercised its ...

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus erythematosus and plaque psoriasis, and $300 million in funds from Bain Capital.

BioNTech’s oncology strategy centers on a bispecific antibody that the company envisions as the backbone of many potential drug combinations for many types of cancer. Bristol Myer Squibb is buying ...

Automotive BMS must undergo rigorous testing to verify that it meets stringent performance and safety standards. BMS emulation involves using hardware and software tools to simulate the behavior of a ...

A former BMS Re employee has filed a lawsuit in the New York Supreme Court, alleging that the company is preventing them from accepting positions at competitor Guy Carpenter by enforcing noncompete ...

BMS Group (BMS), a re/insurance broker, has introduced BMS Bacchus, a specialised stock throughput insurance solution for wineries. Designed to protect wine throughout its lifecycle—from grape harvest ...

BMS’s reinsurance business has doubled in size in the past five years – and must double again, according to CEO Nick Cook. In an interview with this publication, Cook also said that the recent ...

BMS Re, the reinsurance arm of global broker BMS Group, has appointed Brad Melvin (pictured above) as president and chief executive officer of BMS Re US, effective in November. Melvin will report to ...

Hyundai Motor Group (HMG) said it planned to make its battery management system (BMS) available in all its forthcoming electric vehicles (EVs) to alleviate growing concerns over battery safety ...

Bristol Myers Squibb is axing another big bet from the Caforio era, terminating a deal for Agenus’ TIGIT bispecific antibody three years after paying $200 million to buy into the program. Agenus ...